tiprankstipranks
Trending News
More News >
Hyloris Pharmaceuticals SA (DE:52U)
FRANKFURT:52U
Germany Market

Hyloris Pharmaceuticals SA (52U) Ratios

Compare
6 Followers

Hyloris Pharmaceuticals SA Ratios

DE:52U's free cash flow for Q4 2024 was €0.98. For the 2024 fiscal year, DE:52U's free cash flow was decreased by € and operating cash flow was €-0.40. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.80 5.22 8.80 3.60 31.24
Quick Ratio
8.88 5.22 8.88 3.60 31.24
Cash Ratio
7.53 4.50 7.53 3.34 30.21
Solvency Ratio
-1.55 -1.75 -1.55 -0.75 -0.70
Operating Cash Flow Ratio
-2.28 -1.89 -2.28 -0.75 -2.14
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -0.95 -11.17
Net Current Asset Value
€ 43.98M€ 26.70M€ 43.98M€ 38.57M€ 56.49M
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.04 0.01 0.19 0.12
Debt-to-Equity Ratio
0.02 0.04 0.02 0.26 0.14
Debt-to-Capital Ratio
0.02 0.04 0.02 0.20 0.13
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 <0.01 0.12
Financial Leverage Ratio
1.12 1.22 1.12 1.32 1.17
Debt Service Coverage Ratio
-52.22 -149.80 -52.22 -0.90 -4.41
Interest Coverage Ratio
-47.98 -159.93 -47.98 -18.61 -5.62
Debt to Market Cap
0.00 0.00 0.00 0.03 0.03
Interest Debt Per Share
0.04 0.07 0.04 0.50 0.37
Net Debt to EBITDA
3.72 1.91 3.72 3.50 9.06
Profitability Margins
Gross Profit Margin
96.81%95.54%96.81%96.54%17.14%
EBIT Margin
-395.87%-734.45%-395.87%-346.45%-3516.00%
EBITDA Margin
-387.43%-717.78%-387.43%-348.22%-3527.43%
Operating Profit Margin
-356.08%-766.32%-356.08%-334.24%-3186.86%
Pretax Profit Margin
-364.83%-736.94%-364.83%-364.41%-4082.86%
Net Profit Margin
-364.96%-736.94%-364.96%-374.00%-4083.43%
Continuous Operations Profit Margin
-403.46%-736.94%-403.46%-374.00%-4082.86%
Net Income Per EBT
100.04%100.00%100.04%102.63%100.01%
EBT Per EBIT
102.46%96.17%102.46%109.03%128.12%
Return on Assets (ROA)
-17.41%-32.26%-17.41%-18.25%-10.33%
Return on Equity (ROE)
-19.57%-39.37%-19.57%-24.09%-12.10%
Return on Capital Employed (ROCE)
-18.73%-39.08%-18.73%-21.35%-8.32%
Return on Invested Capital (ROIC)
-18.69%-38.85%-18.69%-17.60%-8.26%
Return on Tangible Assets
-18.49%-35.07%-18.49%-19.14%-10.70%
Earnings Yield
-3.41%-4.31%-3.41%-2.59%-2.91%
Efficiency Ratios
Receivables Turnover
0.72 0.00 0.72 1.33 3.65
Payables Turnover
0.04 0.03 0.04 0.04 0.09
Inventory Turnover
-0.20 0.00 -0.20 0.00 145.00K
Fixed Asset Turnover
2.78 0.97 2.78 10.49 0.99
Asset Turnover
0.05 0.04 0.05 0.05 <0.01
Working Capital Turnover Ratio
0.07 0.06 0.07 0.06 <0.01
Cash Conversion Cycle
-10.25K -12.54K -10.25K -8.67K -3.91K
Days of Sales Outstanding
510.46 0.00 510.46 273.63 100.11
Days of Inventory Outstanding
-1.82K 0.00 -1.82K 0.00 <0.01
Days of Payables Outstanding
8.94K 12.54K 8.94K 8.94K 4.01K
Operating Cycle
-1.31K 0.00 -1.31K 273.63 100.12
Cash Flow Ratios
Operating Cash Flow Per Share
-0.48 -0.46 -0.48 -0.44 -0.18
Free Cash Flow Per Share
-0.51 -0.48 -0.51 -0.48 -0.20
CapEx Per Share
0.03 0.01 0.03 0.04 0.02
Free Cash Flow to Operating Cash Flow
1.06 1.06 1.06 1.09 1.14
Dividend Paid and CapEx Coverage Ratio
-17.80 -42.98 -17.80 -10.60 -7.34
Capital Expenditure Coverage Ratio
-17.80 -42.98 -17.80 -10.60 -7.34
Operating Cash Flow Coverage Ratio
-14.86 -7.31 -14.86 -0.92 -0.54
Operating Cash Flow to Sales Ratio
-4.46 -6.14 -4.46 -3.63 -26.11
Free Cash Flow Yield
-4.40%-3.80%-4.40%-2.75%-2.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-29.30 -23.21 -29.30 -38.60 -34.34
Price-to-Sales (P/S) Ratio
106.92 171.06 106.92 144.35 1.40K
Price-to-Book (P/B) Ratio
5.73 9.14 5.73 9.30 4.16
Price-to-Free Cash Flow (P/FCF) Ratio
-22.71 -26.33 -22.71 -36.30 -47.26
Price-to-Operating Cash Flow Ratio
-23.99 -27.87 -23.99 -39.72 -53.70
Price-to-Earnings Growth (PEG) Ratio
2.64 -0.62 2.64 -0.64 0.45
Price-to-Fair Value
5.73 9.14 5.73 9.30 4.16
Enterprise Value Multiple
-23.87 -21.92 -23.87 -37.95 -30.69
Enterprise Value
272.94M 328.35M 272.94M 409.18M 189.46M
EV to EBITDA
-23.87 -21.92 -23.87 -37.95 -30.69
EV to Sales
92.49 157.33 92.49 132.16 1.08K
EV to Free Cash Flow
-19.65 -24.22 -19.65 -33.24 -36.48
EV to Operating Cash Flow
-20.75 -25.64 -20.75 -36.37 -41.46
Tangible Book Value Per Share
1.89 1.26 1.89 1.75 2.19
Shareholders’ Equity Per Share
2.02 1.40 2.02 1.86 2.29
Tax and Other Ratios
Effective Tax Rate
>-0.01 0.00 >-0.01 -0.03 >-0.01
Revenue Per Share
0.11 0.07 0.11 0.12 <0.01
Net Income Per Share
-0.40 -0.55 -0.40 -0.45 -0.28
Tax Burden
1.00 1.00 1.00 1.03 1.00
Interest Burden
0.92 1.00 0.92 1.05 1.16
Research & Development to Revenue
3.44 6.91 3.44 1.63 19.50
SG&A to Revenue
1.19 2.66 1.19 0.94 12.54
Stock-Based Compensation to Revenue
0.19 0.26 0.19 0.19 2.77
Income Quality
1.22 0.83 1.22 0.97 0.64
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis